首页
产品目录
分子砌块
按官能团
羧酸类
rel-4-((1S,2S,3aR,8bR)-2-羟基-1-((3R,E)-3-羟基-4-甲基辛-1-烯-6-炔-1-基)-2,3,3a,8b-四氢-1H-环戊并[b]苯并呋喃-5-基)丁酸钠
rel-4-((1S,2S,3aR,8bR)-2-羟基-1-((3R,E)-3-羟基-4-甲基辛-1-烯-6-炔-1-基)-2,3,3a,8b-四氢-1H-环戊并[b]苯并呋喃-5-基)丁酸钠
rel-Sodium 4-((1S,2S,3aR,8bR)-2-hydroxy-1-((3R,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
产品编号 :
ACQNGY512
Cas No. :
496807-11-5
包装规格
纯度
目录价
会员专享价
库存
数量
1mg
98%
¥1270
询价
5mg
98%
¥3811
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
496807-11-5
中文名称
rel-4-((1S,2S,3aR,8bR)-2-羟基-1-((3R,E)-3-羟基-4-甲基辛-1-烯-6-炔-1-基)-2,3,3a,8b-四氢-1H-环戊并[b]苯并呋喃-5-基)丁酸钠
英文名称
rel-Sodium 4-((1S,2S,3aR,8bR)-2-hydroxy-1-((3R,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
别名
sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate;Beraprost sodium (Relative stereochemistry);Beraprost Impurity 10 Sodium Salt;Beraprost impurity 27;Beraprost Sodium (Mixture of Diastereomers)
标准英文名
sodium 4-((1S,2S,3aR,8bR)-2-hydroxy-1-((3R,E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate
分子式
C2 4 H2 9 NaO5
分子量
420.48
精确分子量
420.19
SMILES
CC#CCC(C)[C@@H](O)/C=C/[C@H]1[C@@H]2C3=C(O[C@@H]2C[C@@H]1O)C(CCCC(=O)[O-])=CC=C3.[Na+]
标准SMILES
[Na+].CC(CC#CC)[C@@H](O)/C=C/[C@H]1[C@H]2[C@@H](C[C@@H]1O)OC1=C2C=CC=C1CCCC([O-])=O
用途
Beraprost sodium is a stable, orally active prostacyclin (PGI2) prodrug with potent vasodilatory effects; it shows potential for the treatment of pulmonary arterial hypertension by dilating renal vessels and improving microcirculation; it promotes angiogenic activity by enhancing tube formation and restoring endothelial cell morphology under hypoxic conditions; it mitigates the development of renal interstitial fibrosis and reduces renal oxidative stress through its vasodilatory properties.
InChIKey
YTCZZXIRLARSET-WGMXHSAISA-M